Literature DB >> 20175245

[Research advances on regulation of Pseudomonas aeruginosa biofilm formation and its therapeutic strategies].

Wen-min Wang1, Zhi-hao Xu.   

Abstract

Pseudomonas aeruginosa is an important pathogenic bacterium of nosocomial infections. The microbe easily produce biofilm which brings us much difficulties in clinical treatment. The formation processes of biofilm, including the stages of early bacteria planting, mushroom-like structure forming and extracellular matrix producing, are regulated by a series of molecules and genes. And quorum sensing system of the microbe is responsible for regulation of the whole process of biofilm formation. According to the process of biofilm formation and the mimitat associated regulation mechanism, several anti-biofilm therapeutic strategies have been applied in clinical medicine, and some novel drugs and methods are developed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20175245     DOI: 10.3785/j.issn.1008-9292.2010.01.018

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  3 in total

1.  Expression, purification, crystallization and preliminary crystallographic analysis of PA3885 (TpbA) from Pseudomonas aeruginosa PAO1.

Authors:  Wen Yang; Kan Li; Yuwei Bai; Ruimin Zhou; Weihong Zhou; Mark Bartlam
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-10-28

2.  Structural and Biochemical Analysis of Tyrosine Phosphatase Related to Biofilm Formation A (TpbA) from the Opportunistic Pathogen Pseudomonas aeruginosa PAO1.

Authors:  Kun Xu; Shanshan Li; Wen Yang; Kan Li; Yuwei Bai; Yueyang Xu; Jin Jin; Yingying Wang; Mark Bartlam
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

3.  C4-HSL aptamers for blocking qurom sensing and inhibiting biofilm formation in Pseudomonas aeruginosa and its structure prediction and analysis.

Authors:  Meng Zhao; Weibin Li; Kuancan Liu; Huiling Li; Xiaopeng Lan
Journal:  PLoS One       Date:  2019-02-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.